GGrantIndex
Sort

50,496 grants matching lung cancer

Insights in Structure-Function Relationships of Matrix Metalloproteinase-1 from Computational and Experimental Studies

$439,609
Tatyana Karabencheva-Christova · Michigan Technological University · R15 · FY2020 · GM

Engineered hybrid aging model for disease progression

$439,567
Pinar Zorlutuna · University Of Notre Dame · R01 · FY2024 · CA

Targeting the metastasis initiating cell in undifferentiated pleomorphic sarcoma

$439,528
Benjamin Aaron Alman · Duke University · R01 · FY2023 · CA

Targeting the metastasis initiating cell in undifferentiated pleomorphic sarcoma

$439,524
Benjamin Aaron Alman · Duke University · R01 · FY2022 · CA

Developmental Funds

$439,520
Juanita L Merchant · University Of Arizona · P30 · FY2023 · CA

Developmental Funds

$439,520
Juanita L Merchant · University Of Arizona · P30 · FY2024 · CA

Project 4: Quantification and Biomarkers of Short-Term Pulmonary Effect p302-340

$439,484
Carolyn Calfee · University Of California, San Francisco · P50 · FY2013 · CA

Development of SHP2 inhibitors for targeted anti-cancer therapy

$439,449
Zhong-Yin Zhang · Purdue University · R01 · FY2019 · CA

Collaborative Research: A Generalizable Data Framework Towards Precision Radiotherapy

$439,440
Jun Deng · Yale University · · FY2019 · MPS

Integrated Chemoselective and Informatic Platform for Large-Scale Metabolomics

$439,402
Teresa W-M Fan · University Of Kentucky · R01 · FY2014 · ES

The Metastatic Cascade: Macrophages Lead the Way

$439,400
Jeffrey W. Pollard · Albert Einstein College Of Medicine, Inc · R01 · FY2017 · CA

The Metastatic Cascade: Macrophages Lead the Way

$439,400
Jeffrey W. Pollard · Albert Einstein College Of Medicine, Inc · R01 · FY2016 · CA

The Metastatic Cascade: Macrophages Lead the Way

$439,399
Jeffrey W. Pollard · Albert Einstein College Of Medicine · R01 · FY2015 · CA

Accurate MR-based PET Attenuation Correction for Quantitative Clinical Trials

$439,398
Raymond F Muzic · Case Western Reserve University · R01 · FY2019 · CA

Relating DNA Adducts and Toxicogenomics

$439,367
Paul Vouros · Northeastern University · R01 · FY2007 · CA

Clinical Pharmacology and Drug-Drug Interactions in HIV-Associated Malignancy

$439,362
William Douglas Figg · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Training in Translational Research of Lung, Head and Neck Cancer

$439,355
Xiao-Jing Wang · University Of Colorado Denver · T32 · FY2016 · CA

In Vivo Studies of the Epileptic Hippocampus

$439,337
Jerome None Engel · University Of California Los Angeles · R01 · FY2012 · NS

INTERPRETABLE MACHINE LEARNING FOR MOLECULAR DISCOVERY IN LUNG CANCER

$439,297
Dana-Farber Cancer Institute, Inc. · · FY2025 · Defense Health Agency

TGF-beta Suppression and Promotion of Mammary Carcinomas

$439,217
Harold L Moses · Vanderbilt University · R01 · FY2014 · CA

Bi-directional interactions with tumor microenvironment enhance BRCA1-IRIS overexpressing TNBC tumor cells aggressiveness

$439,200
Wael M. Elshamy · San Diego Biomedical Research Institute · R01 · FY2018 · CA

Exploiting POU2F3 addiction in the tuft cell variant of small cell lung cancer

$439,200
Christopher Vakoc · Cold Spring Harbor Laboratory · U01 · FY2019 · CA

Exploiting POU2F3 addiction in the tuft cell variant of small cell lung cancer

$439,200
Christopher Vakoc · Cold Spring Harbor Laboratory · U01 · FY2020 · CA

Exploiting POU2F3 addiction in the tuft cell variant of small cell lung cancer

$439,200
Christopher Vakoc · Cold Spring Harbor Laboratory · U01 · FY2021 · CA

The role of amphiregulin in mediating radiation cystitis in cancer survivors

$439,160
Bernadette Margaretha Maria Zwaans · William Beaumont Hospital Research Inst · R01 · FY2023 · DK